Literature DB >> 10667496

Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels.

L Larsson1, X Li, L Edström, L I Eriksson, H Zackrisson, C Argentini, S Schiaffino.   

Abstract

OBJECTIVE: Long-term treatment with nondepolarizing neuromuscular blocking agents and corticosteroids in the intensive care unit is not benign, and an increasing number of patients with acute quadriplegic myopathy have been reported with increased use of these drugs. The purpose of this study was to investigate the mechanisms underlying acute quadriplegic myopathy.
DESIGN: Percutaneous muscle biopsy samples were obtained, and electrophysiologic examinations were performed during the acute phase and during recovery in patients with acute quadriplegic myopathy. Regulation of muscle contraction and myofibrillar protein synthesis was studied using cell physiologic techniques, ultrasensitive electrophoresis, in situ hybridization, and histopathologic techniques.
SETTING: All patients were seen in the intensive care unit of different university hospitals. PATIENTS: All patients were critically ill with sepsis. They had been given massive doses of corticosteroids in combination with variable doses of neuromuscular blocking agents. All patients developed paralysis of spinal nerve-innervated muscles. On the other hand, cranial nerve-innervated muscle and sensory and cognitive functions were well maintained after discontinuation of treatment with neuromuscular blocking agents. INTERVENTION: Muscle biopsy samples were obtained and electrophysiologic examinations were performed in all patients.
MEASUREMENTS AND MAIN RESULTS: The major observations in patients with acute quadriplegic myopathy were, as follows: a) a general decrease in myofibrillar protein content; b) specific but highly variable partial or complete loss of myosin and myosin-associated proteins; c) very low thick-filament/thin-filament protein ratios; d) absence of myosin messenger RNA; and e) a dramatically impaired muscle cell force-generating capacity in the acute phase of acute quadriplegic myopathy. During clinical improvement, normal expression of myosin messenger RNAs, reexpression of thick-filament proteins, and increased specific tension were observed.
CONCLUSIONS: Acute quadriplegic myopathy is associated with a specific decrease in thick-filament proteins related to an altered transcription rate. Although the decreased content of thick-filament proteins is important for prolonged muscle weakness, it is not the primary cause of muscle paralysis in the acute stage, during which impaired muscle membrane excitability probably plays a more significant role. Several factors contribute to this condition, but the action of corticosteroids seems to be the predominant one, along with potentiation by neuromuscular blocking agents, immobilization, and probably also concurrent sepsis.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10667496     DOI: 10.1097/00003246-200001000-00006

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  59 in total

Review 1.  Aging-related changes in skeletal muscle. Mechanisms and interventions.

Authors:  L Larsson; B Ramamurthy
Journal:  Drugs Aging       Date:  2000-10       Impact factor: 3.923

2.  Chronic heart failure decreases cross-bridge kinetics in single skeletal muscle fibres from humans.

Authors:  Mark S Miller; Peter VanBuren; Martin M LeWinter; Joan M Braddock; Philip A Ades; David W Maughan; Bradley M Palmer; Michael J Toth
Journal:  J Physiol       Date:  2010-08-19       Impact factor: 5.182

3.  Scaling of skeletal muscle shortening velocity in mammals representing a 100,000-fold difference in body size.

Authors:  James O Marx; M Charlotte Olsson; Lars Larsson
Journal:  Pflugers Arch       Date:  2005-12-07       Impact factor: 3.657

4.  Neurally adjusted ventilatory assist improves patient-ventilator interaction.

Authors:  Lise Piquilloud; Laurence Vignaux; Emilie Bialais; Jean Roeseler; Thierry Sottiaux; Pierre-François Laterre; Philippe Jolliet; Didier Tassaux
Journal:  Intensive Care Med       Date:  2010-09-25       Impact factor: 17.440

Review 5.  Glucocorticoid receptor signaling in health and disease.

Authors:  Mahita Kadmiel; John A Cidlowski
Journal:  Trends Pharmacol Sci       Date:  2013-08-14       Impact factor: 14.819

6.  Review of Critical Illness Myopathy and Neuropathy.

Authors:  Starane Shepherd; Ayush Batra; David P Lerner
Journal:  Neurohospitalist       Date:  2016-08-23

Review 7.  Corticosteroid-induced adverse events in adults: frequency, screening and prevention.

Authors:  Laurence Fardet; Abdulrhaman Kassar; Jean Cabane; Antoine Flahault
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 8.  Dysregulation of sodium channel gating in critical illness myopathy.

Authors:  James W Teener; Mark M Rich
Journal:  J Muscle Res Cell Motil       Date:  2006-07-28       Impact factor: 2.698

9.  IL-1α reversibly inhibits skeletal muscle ryanodine receptor. a novel mechanism for critical illness myopathy?

Authors:  Oliver Friedrich; Bing Yi; Joshua N Edwards; Barbara Reischl; Anette Wirth-Hücking; Andreas Buttgereit; Roland Lang; Cornelia Weber; Fabian Polyak; Ilon Liu; Frederic von Wegner; Tanya R Cully; Aven Lee; Patrick Most; Mirko Völkers
Journal:  Am J Respir Cell Mol Biol       Date:  2014-06       Impact factor: 6.914

10.  Skeletal muscle contractile protein function is preserved in human heart failure.

Authors:  Yoko Okada; Michael J Toth; Peter Vanburen
Journal:  J Appl Physiol (1985)       Date:  2008-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.